Delaware's top court reversed a ruling that allowed expert testimony in Zantac cancer lawsuits, citing improper legal ...

The Delaware Supreme Court rejected the legitimacy of expert testimony linking the heartburn drug Zantac to cancer, in a ...

In the latest twist in the ocean of Zantac-related litigation playing out across state courts, drugmakers have notched a key ...

Delaware's highest court ruled on Thursday that nearly 75,000 patients suing four large drugmakers cannot introduce reports ...

Zantac, and all ranitidine products, should be removed from shelves, as the FDA cites carcinogen NDMA concerns. The U.S. Food and Drug Administration Wednesday said Zantac should be removed from ...

Over 75,000 plaintiffs filed suit in Delaware Superior Court alleging that ranitidine, which several manufacturers market under the trade name Zantac, caused their cancer.

CVS and Walgreens quit selling heartburn drug Zantac and generic ranitidine products during an ongoing FDA investigation into possible cancer risks. $3,500 iPhone possible? What to know 📋 How ...

Lab investigates heartburn drug’s possible cancer link 04:53. The popular heartburn drug ranitidine, the generic form of Zantac, was linked to cancer in September, prompting some voluntary ...

One medication stood out: Zantac and its generic version, Ranitidine. It had high levels of NDMA. Packages and pills of Zantac seen on September 19, 2019, in New York City.

A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of thousands of lawsuits making ...

Answer: On Sept. 13, the FDA announced some ranitidine medicines, including those sold under the brand Zantac, contained "low levels" of the NDMA impurity, a probable human carcinogen.

Zantac, and all ranitidine products, should be removed from shelves, as the FDA cites carcinogen NDMA concerns. The U.S. Food and Drug Administration Wednesday said Zantac should be removed from ...